Founding members span Big Tech, healthcare, payers, and patient groups to define what good looks like for trusted AI-enabled care…
Together with cash on hand, the fully leveraged facility extends Aptevo's funding runway into 2029, enabling achievement of key clinical…
CASTRES, France and PARIS, Jan. 9, 2026 /PRNewswire/ -- Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and…
Electrome Bioelectric Therapeutics Platform being used to explore inhibition of pathogen motility and persistence, with implications for infectious disease, pharma,…
The refreshed Dr. Weil's Anti-Inflammatory Food Pyramid™ modernizes one of the best-ranked diets by U.S. News & World Report and…
Combined teams and proprietary AI-technology to multiply capabilities and services as a leading provider of real-world data for clinical researchSAN…
Tony Hunter, Ph.D., celebrated for pioneering discoveries that inspired the development of more than 80 cancer therapies that continue to…
1H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune Disease Interim Futility Analysis of…
Received $35.8 million in gross proceeds from Series B warrant exercises, including full exercise by Coastlands Capital, Frazier Life Sciences…
- First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s choice of chemotherapy…